Results 71 to 80 of about 3,062,730 (403)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Cylindrical illumination with angular coupling for whole-prostate photoacoustic tomography [PDF]

open access: yes, 2019
Current diagnosis of prostate cancer relies on histological analysis of tissue samples acquired by biopsy, which could benefit from real-time identification of suspicious lesions.
Bungart, Brittani   +9 more
core   +1 more source

BREAST CORE NEEDLE BIOPSY

open access: yese-Jurnal Medika Udayana, 2013
Nowadays, there are many kinds of biopsy. One that can be done in breast is core needle biopsy. Core needle biopsy is a tissue sampling procedure using hollow core needle size 11-16 gauge.
Reni Widyastuti   +2 more
doaj  

Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.

open access: yesPLoS ONE, 2014
ObjectiveTransperineal ultrasound-guided (TPUS) 12-core prostate biopsy was evaluated as an initial strategy for the diagnosis of prostate cancer, The distribution of prostate cancer lesions was assessed with zone-specific biopsy.MethodsFrom January 2010
Ming-Hua Yao   +7 more
doaj   +1 more source

Accuracy of Core Needle Biopsy Versus Fine Needle Aspiration Cytology for Diagnosing Salivary Gland Tumors [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2015
Background: Core needle biopsy is a relatively new technique used to diagnose salivary gland lesions, and its role in comparison with fine needle aspiration cytology needs to be refined.
In Hye Song   +9 more
doaj   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer. A pilot study [PDF]

open access: yes, 2015
Background: The spread of mammographic screening programs has allowed an increasing amount of early breast cancer diagnosis. A modern approach to non-palpable breast lesions requires an accurate intraoperative localization, in order to achieve a ...
Anibaldi, Paolo   +8 more
core   +2 more sources

Changing Paradigms in Breast Carcinoma:A Review

open access: yesJournal of Medical Sciences and Health, 2015
The journey of breast cancer a common malignancy the world over, is long drawn with several ups and downs finally resulting in patterns of management and therapy amounting to an attempt at breast conservation.
Shameem Shariff
doaj  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

open access: yesMolecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy